Please note that the recruitment of patients to VIABLE clinical trial was successfully completed.

OK

View the Map

Participating Medical Centers

You have entered website for VIABLE study – phase III global clinical trial for prostate cancer treatment (DCVAC/PCa). This clinical trial is intended for patients with metastatic castration- resistant prostate cancer, who meet the entry criteria and consent to participate.

Only a physician conducting a clinical evaluation of an investigational treatment DCVAC/PCa can decide whether or not a patient can be included in a clinical trial. This is based on the criteria defined in the study protocol which is approved by the health care authorities.

The term “investigational treatment” means that it has not yet been approved by the European Medicines Agency (EMA) or Food and Drug Administration (FDA) for the treatment of prostate cancer.

You can find the participating medical centres listed below.

The Netherlands

Participating Medical Center Address Principal investigator Phone  
VUMC, Afdeling Medische Oncologie
De Boelelaan 1117,
1081 HV Amsterdam
Dr. van der Eertwegh +31 204 444 336 E-mail
Wilhelmina Ziekenhuis Assen,
Oncologie
Europaweg-Zuid 1, Interne Geneeskunde,
9401 RK Assen
Dr. Peter Nieboer +31 592325155 E-mail
Ziekenhuis Tergooi, locatie Hilversum
Interne Geneeskunde
Van Riebeeckweg 212,
1213 XZ Hilversum
Dr. van der Berg +31 643 795 276 E-mail
Spaarne Ziekenhuis
Oncologie
Spaarnepoort 1,
2134 TM Hoofddorp
Dr. Beeker +31 238 907 155 E-mail
Medisch Centrum Leeuwarden
Oncologie
Henri Dunantweg 2,
8934 AD Leeuwarden
Dr. Polee +31 582 866 660 E-mail
UMC St. Radboud Nijmegen
Oncologie
Geert Grooteplein-Zuid 10,
6525 GA Nijmegen
Professor Gerritsen +31 243 618 800 E-mail
Maasstad Ziekenhuis
Oncologie
Maasstadweg 21,
3079 DZ Rotterdam
Dr. T. C. Kok +31 102 911 350 E-mail